Risk stratification for arrhythmic death after myocardial infarction: Current perspective and future direction

International Journal of Cardiology

Volumn 108, Issue 2, 2006, Pages 155-164

  Arya, Arash ^a   Haghjoo, Majid ^a   Ali Sadr Ameli, Mohammad ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Defibrillators; Electrophysiology; Implantable; Mortality; Myocardial infarction; Risk stratification

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; DECISION MAKING; DEFIBRILLATOR; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; MORTALITY; PATIENT SELECTION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; QT DISPERSION; REVIEW; RISK ASSESSMENT; SUDDEN DEATH;

ALGORITHMS; ARRHYTHMIA; BAROREFLEX; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; HEART RATE; HUMANS; MYOCARDIAL INFARCTION; RISK ASSESSMENT; SIGNAL PROCESSING, COMPUTER-ASSISTED; STROKE VOLUME;

EID: 33644698172     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.05.011     Document Type: Review

References (101)

1. A.J. Moss, W. Zareba, W.J. Hall Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
2. M.R. Bristow, L.A. Saxon, and J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
3. G.H. Bardy, K.L. Lee, D.B. Mark for the The Sudden Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
4. J. Camm Risk stratification for ventricular tachyarrhythmic events by noninvasive methods is possible Presented at heart rhythm society scientific sessions 2004 San Francisco, California, United States, May 19-22 2004
5. D.K. Owens, G.D. Sanders, and R.A. Harris Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death Ann Intern Med 126 1997 1 12
6. S.H. Hohnloser, and B.J. Gersh Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator Circulation 107 2003 941 946
7. The Multicenter Postinfarction Research Group Risk stratification and survival after myocardial infarction N Engl J Med 309 1983 331 336
8. J.T. Bigger Jr., J.L. Fleiss, R. Kleiger, J.P. Miller, and L.M. Rolnitzky The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction Circulation 69 1984 250 258
9. J. Mukharji, R.E. Rude, W.K. Poole The MILIS Study Group Risk factors for sudden death after acute myocardial infarction: two-year follow-up Am J Cardiol 54 1984 31 36
10. J. Coromilas, J.T. Bigger Jr., R.E. Kleiger The MDPIT Research Group Relations among left ventricular dysfunction, ventricular arrhythmias, and mortality after myocardial infarction Circulation 80 Suppl. II 1989 48
11. Y.G. Yap, T. Duong, and M. Bland Left ventricular ejection fraction in the thrombolytic era remains a powerful predictor of long term but not short-term all cause cardiac and arrhythmicmortality after myocardial infarction-a secondary meta-analysis of 2828 patients J Am Coll Cardiol 37 Suppl. A 2001 445A
12. A.J. Moss, W.J. Hall, and D.S. Cannom Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias N Engl J Med 335 1996 1933 1940
13. A.J. Moss, Y. Fadl, W. Zareba, and D.S. Cannom Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease Am J Cardiol 88 2001 516 520
14. A.E. Buxton for the The Multicenter Unsustained Tachycardia Trial Investigators A randomized study of the prevention of sudden death in patients with coronary artery disease N Engl J Med 341 1999 1882 1890
15. A.E. Buxton, K.L. Lee, and G.E. Hafley Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial Circulation 106 2002 2466 2472
16. A.J. Moss MADIT II and its implications Eur Heart J 24 2003 16 18
17. J.A. Gomes, S.L. Winters, and D. Stewart A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on digital-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring J Am Col Cardiol 10 1987 349 357
18. A.E. Buxton, K.L. Lee, and L. DiCarlo Electrophysiologic testing to identify patients with coronary artery disease who are at high risk for sudden death N Engl J Med 342 2000 1937 1945
19. M.A. Brodsky, L.B. Mitchell, B.D. Halperin, M.H. Raitt, A.P. Hallstrom for AVID Investigators Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachycardia: The antiarrhythmics versus implantable defibrillators (AVID) trial Am Heart J 144 2002 478 484
20. J.P. Daubert, W. Zareba, and C.D. Schuger Does EPS inducibility in MADIT II patients predict subsequent VT and/or VF events? (Abstract) PACE 26 2003 960
21. E.J. Rashba, A.F. Osman, and K. MacMurdy Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease J Cardiovasc Electrophysiol 15 2004 170 176
22. D. Wichterle, J. Simek, J. Camm, and M. Malik Predictive characteristics of Holter-based postinfarction risk stratifiers appear superior to electrophysiological testing Pacing Clin Electrophysiol 28 2005 S182 S186
23. W.M. Jackman The future of catheter ablation Presented at heart rhythm society scientific sessions 2004 San Francisco, California, United States, May 19-22 2004
24. V. Kalahasti, V. Nambi, and D.O. Martin QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias Am J Cardiol 92 2003 798 803
25. P.R. Kalra, R. Sharma, and W. Shamim Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration Int J Cardiol 86 2002 225 231
26. W. Shamim, M. Yousufuddin, M. Cicoria, D.G. Gibson, A.J. Coats, and M.Y. Henein Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure Heart 88 2002 47 51
27. E.S. Brilakis, N.C. Mavrogiorgos, and S.L. Kopecky Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction Am J Cardiol 89 2002 1013 1018
28. D.M. Bloomfield, R.C. Steinman, and P.B. Namerow Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy a solution to the multicenter automatic defibrillator implantation trial (MADIT) II conundrum Circulation 110 2004 1885 1889
29. M.O. Sweeney, M.H. Schoenfeld, and D.S. Cannom Rules of evidence: CMS and primary prevention of sudden cardiac death in systolic heart failure Pacing Clin Electrophysiol 28 2005 81 88
30. H.J. Shenkman, V. Pampati, and A.K. Khandelwal Congestive heart failure and QRS duration: establishing prognosis study Chest 122 2002 528 534
31. P. Khairy, B. Thibault, and M. Talajic Prognostic significance of ventricular arrhythmia post-myocardial infarction Can J Cardiol 19 2003 1393 1404
32. D.J. Statters, M. Malik, S. Redwood, K. Hnatkowa, A. Staunton, and A.J. Camm Use of ventricular premature complexes for risk stratification after myocardial infarction in the thrombolytic era Am J Cardiol 77 1996 133 138
33. W. Ruberman, E. Weinblatt, J.D. Goldberg, C.W. Frank, and S. Shapiro Ventricular premature beats and mortality after myocardial infarction N Eng J Med 297 1997 750 757
34. A. Drogemuller, K. Seidi, R. Schiele MITRA Study Group Prognostic value of nonsustained ventricular tachycardias after acute myocardial infarction in the thrombolytic era: importance of combination with frequent premature ventricular beats Z Kardiol 92 2003 164 172
35. M. Sosnowski, J. Skrzypek-Wanha, B. Korzeniowska, and M. Tendera Increased variability of the coupling interval of premature ventricular beats may help to identify high-risk patients with coronary artery disease Int J Cardiol 94 2004 53 59
36. J.A. Cairns, S.J. Connoly, M. Gent, and R. Roberts Post myocardial infarction mortality in patients with premature ventricular depolarizations. Canadian amiodarone myocardial infarction trial pilot study Circulation 84 1991 550 557
37. D.S. Echt, P.R. Liebson, and L.B. Mitchell Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial N Eng J Med 324 1991 781 788
38. A.E. Buxton, J. Duc, E.E. Berget, and V. Torres Nonsustained ventricular tachycardia M.H. Crawford J.M. Miller Cardiology clinics: ventricular arrhythmia 2000 W.B. Saunders Co. Philadelphia 327 336
39. D.G. Katritsis, and A.J. Camm Nonsustained ventricular tachycardia: where do we stand? Eur Heart J 25 2004 1093 1099
40. L.A. Pires, M.H. Lehman, A.E. Buxton, G.E. Hafley, K.L. Lee MUSTT Investigators Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications J Am Coll Cardiol 38 2001 1156 1162
41. M.G. Weigner, and A.E. Buxton Nonsustained ventricular tachycardia. A guide to the clinical significance and management Med Clin North Am 85 2001 305 320
42. E.N. Prystowsky Screening and therapy for patients with nonsustained ventricular tachycardia Am J Cardiol 86 Suppl 1 2000 K34 K39
43. H. Schmitt, T. Hurst, M. Coch, H. Killat, B. Wunn, and B. Waldecker Nonsustained asymptomatic ventricular tachycardia in patients with coronary artery disease: prognosis and incidence of sudden death of patients who are noninducible by electrophysiology testing Pacing Clin Electrophysiol 23 2000 1220 1225
44. S.H. Hohnloser, T. Klingenheben, M. Zabel, M. Schopperl, and O. Mauss Prevalence, characteristics and prognosis value during long-term follow up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era J Am Coll Cardiol 33 1999 1895 1902
45. M.H. Kim, D. Bruckman, M.M. Kirsh, and W.H. Kou Outcome of men with ischemic cardiomyopathy, nonsustained ventricular tachycardia, and negative electrophysiologic study Am J Cardiol 85 2000 119 121
46. A.P. Maggioni, G. Zuanetti, and M.G. Franzosi Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results Circulation 87 1993 312 322
47. D.L. Kuchar, C.W. Thorburn, and L. Sammel Prediction of serial arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring, and radionuclide ventriculography J Am Coll Cardiol 9 1987 531 538
48. J.A. Gomes, S.L. Winters, and M. Martinson The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study J Am Coll Cardiol 13 1988 277 284
49. N. el-Sherif, P. Denes, and R. Katz Definition of the best prediction criteria of the time-domain signal-averaged electrocardiogram for serious arrhythmia events in the post-infarction period J Am Coll Cardiol 25 1995 908 914
50. E.J. Berbari High resolution electrocardiography D.P. Zipes J. Jalife Cardiac electrophysiology from cell to bedside Philadelphia, PN, USA 4th ed. 2004 W.B. Saunders Inc. 793 802
51. J.T. Bigger for the CABG-Patch trial investigators Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery N Engl J Med 337 1997 1569 1575
52. M. Malik Heart rate variability and baroreflex sensitivity D.P. Zipes J. Jalife Cardiac electrophysiology from cell to bedside Philadelphia, PN, USA 4th ed. 2004 W.B. Saunders Inc. 823 830
53. P.K. Stein, P.P. Domitrovich, H.V. Huikuri, R.E. Kleiger for the CAST investigators Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction J Cardiovasc Electrophysiol 16 2005 13 20
54. R.E. Klieger, J.P. Miller, J.T. Bigger, and A.J. Moss Decreased heart rate variability and its association with increased mortality after acute myocardial infarction Am J Cardiol 59 1987 256 262
55. G. Zuanetti, J.M. Neilson, R. Latini, E. Santoro, A.P. Maggioni, and D.J. Ewing Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era Circulation 94 1996 432 436
56. M. Malik, A.J. Camm, M.J. Janse, D.G. Julian, G.A. Frangin, and P.J. Schwartz Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarction Amiodarone Trial) J Am Coll Cardiol 35 2000 1263 1275
57. D. Wichterle, J. Simek, M.T. La Rovere, P.J. Schwartz, A.J. Camm, and M. Malik Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction Circulation 110 2004 1183 1190
58. S.H. Hohnloser, K.H. Kuck, P. Dorian on behalf of the DINAMIT Investigators Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488
59. M.T. La Rovere, J.T. Bigger, F.I. Marcus, A. Mortara, P.J. Schwartz for the ATRAMI investigators Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction Lancet 351 1998 478 484
60. M.T. La Rovere, G. Specchia, A. Mortara, and P.G. Schwartz Baroreflex sensitivity, clinical correlates and cardiovascular mortality among patients with a first myocardial infarction: a prospective study Circulation 78 1988 816 824
61. T.G. Farrell, O. Odemuyiwa, and Y. Bashir Prognostic value of baroreflex sensitivity testing after acute myocardial infarction Br Heart J 67 1992 129 137
62. N. Honzikowa, B. Fiser, and B. Semrad Critical value of baroreflex sensitivity determined by spectral analysis in risk stratification after myocardial infarction Pacing Clin Electrophysiol 23 2000 1965 1967
63. M.T. La Rovere, G.D. Pinna, and S.H. Hohnloser Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials Circulation 103 2001 2072 2079
64. D. Wichterle, V. Melenowsky, and M. Malik Mechanisms involved in heart rate turbulence Card Electrophysiol Rev 6 2002 262 266
65. G. Schmidt, M. Malik, and P. Barthel Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction Lancet 353 1999 1390 1396
66. P. Barthel, R. Schneider, and A. Bauer Risk stratification after acute myocardial infarction by heart rate turbulence Circulation 108 2003 1221 1226
67. E. Sade, K. Aytemir, and A. Oto Assessment of heart rate turbulence in the acute phase of myocardial infarction for long-term prognosis Pacing Clin Electrophysiol 26 2003 544 550
68. L.Y. Lin, L.P. Lai, and J.L. Lin Tight mechanism correlation between heart rate turbulence and baroreflex sensitivity: sequential autonomic blockade analysis J Cardiovasc Electrophysiol 13 2002 427 431
69. A. Ghuran, F. Reid, and M.T. La Rovere Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The autonomic tone and reflexes after myocardial infarction substudy) Am J Cardiol 89 2002 184 190
70. A. Berkowitsch, W. Zareba, and T. Neuman Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and the limitations of a 10-minute Holter recording Ann Noninvasive Electrocardiol 9 2004 270 279
71. I. Cygankiewicz, J.K. Wranicz, H. Bolinska, J. Zaslonka, and W. Zareba Circadian changes in heart rate turbulence parameters J Electrocardiol 37 2004 297 303
72. K.T. Lee, W.T. Lai, C.S. Chu, H.W. Yen, W.C. Voon, and S.H. Sheu Effect of electrophysiology character of ventricular premature beat on heart rate turbulence J Electrocardiol 37 2004 41 46
73. A. Jeron, T. Kaiser, C. Hengstenberg, H. Lowel, G.A. Riegger, and S. Holmer Association of heart rate turbulence with classic risk stratification parameters in postmyocardial infarction patients Ann Noninvasive Electrocardiol 8 2003 296 301
74. L.U. Lin, J.J. Hwang, and L.P. Lai Restoration of heart rate turbulence by titrated beta-blocker therapy in patients with advanced congestive heart failure: positive correlation with enhanced vagal modulation of heart rate J Cardiovasc Electrophysiol 15 2004 752 756
75. D. Bloomfeild, A.R. Magnano, and J.T. Bigger Heart rate variability, signal-averaged electrocardiography, QT dispersion and T-wave alternans P.J. Podrid P.R. Kowey Cardiac arrhythmia: mechanisms, diagnosis and management 2nd ed. 2001 Lippincott Williams and Wilkins Philadelphia, PN, USA 195 230
76. M. Zabel, and M. Malik Predictive value of T-wave morphology variables and QT dispersion for postmyocardial infarction risk assessment Electrocardiology 34 2001 27 35 [Suppl]
77. E.J. Figueredo, Y. Ohnishi, A. Yoshida, and M. Yokoyama Usefulness of beat-to-beat QT dispersion fluctuation for identifying patients with coronary heart disease at risk for ventricular arrhythmias Am J Cardiol 88 2001 1235 1239
78. H. Jain, and R. Avasthi Correlation between dispersion of repolarization (QT dispersion) and ventricular ectopic beat frequency in patients with acute myocardial infarction: a marker for risk of arrhythmogenesis? Int J Cardiol 93 2004 69 73
79. M.C. Haigney, W. Zareba, and P.J. Gentlesk QT interval variability and spontaneous ventricular tachycardia or fibrillation in the multicenter automatic defibrillator implantation trial (MADIT) II patients J Am Coll Cardiol 44 2004 1481 1488
80. A.A. Armoundas, G.F. Tomaselli, and H.D. Esperer Pathophysiological basis and clinical application of T-wave alternans J Am Coll Cardiol 40 2002 207 217
81. D.R. Adam, A.O. Powell, H. Gordon, and R.J. Cohen Ventricular fibrillation and fluctuations in the magnitude of the repolarization vector IEEE Comput Cardiol 1982 241 244
82. D.R. Adam, J.M. Smith, S. Akselrod, S. Nyberg, A.O. Powell, and R.J. Cohen Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation J Electrocardiol 17 1984 209 218
83. J.M. Smith, E.A. Clancy, C.R. Valeri, J.N. Ruskin, and R.J. Cohen Electrical alternans and cardiac electrical instability Circulation 77 1988 110 121
84. D.S. Rosenbaum, L.E. Jackson, J.M. Smith, H. Garan, J.N. Ruskin, and R.J. Cohen Electrical alternans and vulnerability to ventricular arrhythmias N Engl J Med 330 1994 235 241
85. T. Ikeda, T. Sakata, and M. Takami Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study J Am Coll Cardiol 35 2000 722 730
86. R.L. Verrier, B.D. Nearing, and K.F. Kwaku Noninvasive sudden death risk stratification by ambulatory ECG-based T-wave alternans analysis: evidence and methodological guidelines Ann Noninvasive Electrocardiol 10 2005 110 120
87. J.M. Tapanainen, A.M. Still, K.E.J. Airaksinen, and H.V. Huikuri Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow-up study J Cardiovasc Electrophysiol 12 2001 645 652
88. T. Ikeda, H. Saito, and K. Tanno T-wave alternans as a predictor for sudden cardiac death after myocardial infarction Am J Cardiol 89 2002 79 82
89. K. Tanno, S. Ryu, and N. Watanabe Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias: a prospective study using atrial pacing Circulation 109 2004 1854 1858
90. T wave alternans in congestive heart failure (TWA-CHF) trial http://www. hrsonline.org/professional_education/learning_categories/clinical_trials/ twainchf/ Accessed November 4, 2004
91. R.J. Cohen Enhancing specificity without sacrificing sensitivity: potential benefits of using microvolt T-wave alternans testing to risk stratify the MADIT-II population Card Electrophysiol Rev 7 2003 438 442
92. E.J. Rashba, A.F. Osman, and K. Macmurdy Influence of QRS duration on the prognostic value of T wave alternans J Cardiovasc Electrophysiol 13 2002 770 775
93. L.A. Pires T-wave alternans and ventricular arrhythmia risk stratification: uses and limitations J Cardiovasc Electrophysiol 13 2002 776 777
94. S.R. Shorofsky, and M.R. Gold T-wave alternans: predictor of arrhythmic events? Facts or fiction J Cardiovasc Electrophysiol 13 2002 513 514
95. D.S. Rosenbaum T-wave alternans: a mechanism of arrhythmogenesis comes of age after 100 years J Cardiovasc Electrophysiol 13 2001 207 209
96. R.L. Verrier, B.D. Nearing, and M.T. La Rovere Ambulatory electrocardiogram-based tracking of T-wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death J Cardiovasc Electrophysiol 14 2003 705 711
97. M.R. Gold, D.M. Bloomfield, and K.P. Anderson A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification J Am Coll Cardiol 36 2000 2247 2253
98. Cambridge heart lunches "Master" study identifying patients in most urgent need of implantable cardiac defibrillators www.cambridgeheart.com/ camh/media /releases/pr030915.html Accessed November 4, 2004
99. M.J. Raatinainen, V. Jokinen, V. Virtanen, J. Hartikainen, A. Hedman, H.V. Huikuri CARISMA Investigators Microvolt T-wave alternans during exercise and pacing in patients with acute myocardial infarction Pacing Clin Electrophysiol 28 2005 S193 S197
100. M.R. Reynolds, and M.E. Josephson MADIT II (Second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy Circulation 108 2003 1779 1783
101. Decision memo for implantable defibrillators (CAG-00157R3) http:// ww.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=148 Accessed February 10, 2005